The star polymer-docetaxel conjugates exert a much higher therapeutic activity and yet a lower systemic toxicity than free DTX.
No takes yet. Share an insight, caveat, or question.
Etrych et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: